21st Century Cancer Sourcebook: Myelodysplastic / Myeloproliferative (MDS/MPN) Neoplasms, Chronic Myelomonocytic Leukemia (CMML), aCML, Juvenile Myelomonocytic Leukemia (JMML), MDS/MPN-UC

Nonfiction, Health & Well Being, Health, Ailments & Diseases, Cancer
Cover of the book 21st Century Cancer Sourcebook: Myelodysplastic / Myeloproliferative (MDS/MPN) Neoplasms, Chronic Myelomonocytic Leukemia (CMML), aCML, Juvenile Myelomonocytic Leukemia (JMML), MDS/MPN-UC by Progressive Management, Progressive Management
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Progressive Management ISBN: 9781465849649
Publisher: Progressive Management Publication: November 3, 2011
Imprint: Smashwords Edition Language: English
Author: Progressive Management
ISBN: 9781465849649
Publisher: Progressive Management
Publication: November 3, 2011
Imprint: Smashwords Edition
Language: English

Authoritative information and practical advice from the nation's cancer experts about myelodysplastic/myeloproliferative neoplasms includes official medical data on signs, symptoms, early detection, diagnostic testing, risk factors and prevention, treatment options, surgery, radiation, drugs, chemotherapy, staging, biology, prognosis, and survival, with a complete glossary of technical medical terms and current references. The 3 main types of myelodysplastic/myeloproliferative neoplasms include Chronic myelomonocytic leukemia (CMML); Juvenile myelomonocytic leukemia (JMML); and Atypical chronic myelogenous leukemia (aCML). When a myelodysplastic/myeloproliferative neoplasm does not match any of these types, it is called myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-UC).

Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive in-depth compilation gives empowered patients, families, caregivers, nurses, and physicians the knowledge they need to understand the diagnosis and treatment of myelodysplastic/myeloproliferative neoplasms.

Comprehensive data on clinical trials is included - with information on intervention, sponsor, gender, age group, trial phase, number of enrolled patients, funding source, study type, study design, NCT identification number and other IDs, first received date, start date, completion date, primary completion date, last updated date, last verified date, associated acronym, and outcome measures.

Myelodysplastic/myeloproliferative neoplasms are a group of diseases in which the bone marrow makes too many white blood cells. Myelodysplastic /myeloproliferative neoplasms are diseases of the blood and bone marrow. Normally, the bone marrow makes blood stem cells (immature cells) that become mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell. The lymphoid stem cell develops into a white blood cell. The myeloid stem cell develops into one of three types of mature blood cells:

* Red blood cells that carry oxygen and other materials to all tissues of the body.

* White blood cells that fight infection and disease.

* Platelets that help prevent bleeding by causing blood clots to form.

Myelodysplastic/myeloproliferative neoplasms have features of both myelodysplastic syndromes and myeloproliferative disorders. In myelodysplastic diseases, the blood stem cells do not mature into healthy red blood cells, white blood cells, or platelets. The immature blood cells, called blasts, do not work the way they should and die in the bone marrow or soon after they enter the blood. As a result, there are fewer healthy red blood cells, white blood cells, and platelets.

Extensive supplements, with chapters gathered from our Cancer Toolkit series and other reports, cover a broad range of cancer topics useful to cancer patients. This edition includes our exclusive Guide to Leading Medical Websites with updated links to 81 of the best sites for medical information, which let you quickly check for updates from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Supplemental coverage includes:

Levels of Evidence for Cancer Treatment Studies
Glossary of Clinical Trial Terms
Clinical Trials Background Information and In-Depth Program
Clinical Trials at NIH
How To Find A Cancer Treatment Trial: A Ten-Step Guide
Taking Part in Cancer Treatment Research Studies
Access to Investigational Drugs
Clinical Trials Conducted by the National Cancer Institute's Center for Cancer Research at the National Institutes of Health Clinical Center
Taking Time: Support for People with Cancer
Facing Forward - Life After Cancer Treatment
Chemotherapy and You

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Authoritative information and practical advice from the nation's cancer experts about myelodysplastic/myeloproliferative neoplasms includes official medical data on signs, symptoms, early detection, diagnostic testing, risk factors and prevention, treatment options, surgery, radiation, drugs, chemotherapy, staging, biology, prognosis, and survival, with a complete glossary of technical medical terms and current references. The 3 main types of myelodysplastic/myeloproliferative neoplasms include Chronic myelomonocytic leukemia (CMML); Juvenile myelomonocytic leukemia (JMML); and Atypical chronic myelogenous leukemia (aCML). When a myelodysplastic/myeloproliferative neoplasm does not match any of these types, it is called myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-UC).

Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive in-depth compilation gives empowered patients, families, caregivers, nurses, and physicians the knowledge they need to understand the diagnosis and treatment of myelodysplastic/myeloproliferative neoplasms.

Comprehensive data on clinical trials is included - with information on intervention, sponsor, gender, age group, trial phase, number of enrolled patients, funding source, study type, study design, NCT identification number and other IDs, first received date, start date, completion date, primary completion date, last updated date, last verified date, associated acronym, and outcome measures.

Myelodysplastic/myeloproliferative neoplasms are a group of diseases in which the bone marrow makes too many white blood cells. Myelodysplastic /myeloproliferative neoplasms are diseases of the blood and bone marrow. Normally, the bone marrow makes blood stem cells (immature cells) that become mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell. The lymphoid stem cell develops into a white blood cell. The myeloid stem cell develops into one of three types of mature blood cells:

* Red blood cells that carry oxygen and other materials to all tissues of the body.

* White blood cells that fight infection and disease.

* Platelets that help prevent bleeding by causing blood clots to form.

Myelodysplastic/myeloproliferative neoplasms have features of both myelodysplastic syndromes and myeloproliferative disorders. In myelodysplastic diseases, the blood stem cells do not mature into healthy red blood cells, white blood cells, or platelets. The immature blood cells, called blasts, do not work the way they should and die in the bone marrow or soon after they enter the blood. As a result, there are fewer healthy red blood cells, white blood cells, and platelets.

Extensive supplements, with chapters gathered from our Cancer Toolkit series and other reports, cover a broad range of cancer topics useful to cancer patients. This edition includes our exclusive Guide to Leading Medical Websites with updated links to 81 of the best sites for medical information, which let you quickly check for updates from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Supplemental coverage includes:

Levels of Evidence for Cancer Treatment Studies
Glossary of Clinical Trial Terms
Clinical Trials Background Information and In-Depth Program
Clinical Trials at NIH
How To Find A Cancer Treatment Trial: A Ten-Step Guide
Taking Part in Cancer Treatment Research Studies
Access to Investigational Drugs
Clinical Trials Conducted by the National Cancer Institute's Center for Cancer Research at the National Institutes of Health Clinical Center
Taking Time: Support for People with Cancer
Facing Forward - Life After Cancer Treatment
Chemotherapy and You

More books from Progressive Management

Cover of the book Air Force Strategy Study 2020-2030: Power Projection, Freedom of Action in Air, Space, and Cyberspace, Global Situational Awareness, Military Support for Civil Authorities by Progressive Management
Cover of the book Improving Cybersecurity in the Health Care Industry: Report of the Health Care Industry Cybersecurity Task Force - Risks to Medical Devices and IT Systems, Working in the Open Culture of Health Care by Progressive Management
Cover of the book 90,000 Tons of Diplomacy: How the U.S. Navy Supports Naval Aviation - Aircraft Carrier Fleet for America's Worldwide Commitment, Conducting Contingency Operations, History of Naval Aviation Interest by Progressive Management
Cover of the book Unmanned Systems Integrated Roadmap FY2013-2038 - Unmanned Aircraft Systems (UAS), Drones, Unmanned Maritime Systems, Technologies, Logistics, Sustainment, Training, International, Foreign Sales by Progressive Management
Cover of the book Nanoscience and Nanotechnology: National Nanotechnology Initiative Strategic Plan 2011, Designing Materials to Revolutionize and Engineer our Future (DMREF) by Progressive Management
Cover of the book Searching the Skies: The Legacy of the United States Cold War Defense Radar Program - BMEWS, SAGE, NORAD, PAVE PAWS, Spacetrack, Safeguard, Ground Observer Corps (GOC), Whirlwind by Progressive Management
Cover of the book U.S. Army Civil Affairs Forces in the Sahel: Developing an Approach to Building Relevant Partner Capacity in Support of U.S. Africa Command - Examples of Boko Haram in Nigeria, Mali Military Coup by Progressive Management
Cover of the book 21st Century Peacekeeping and Stability Operations Institute (PKSOI) Papers - Lessons Learned from U.S. Government Law Enforcement in International Operations - Panama, Colombia, Kosovo by Progressive Management
Cover of the book RPAs: Revolution or Retrogression? Remotely Piloted Aircraft, Drones, UAV, UAS, Predator, Future Roles and Missions, Is F-35 the Last Manned Fighter, Historical View of the Technology Transition by Progressive Management
Cover of the book Eisenhower: The Most Reasonable of Unreasonable Men: Eisenhower as Strategic General in World War II - Lifelong Student, Supreme Commander, Moral Leader, Extraordinary Personal Energy by Progressive Management
Cover of the book War in the Balkans, 1991-2002: Comprehensive History of Wars Provoked by Yugoslav Collapse: Balkan Region in World Politics, Slovenia and Croatia, Bosnia-Herzegovina, Kosovo, Greece, Turkey, Cyprus by Progressive Management
Cover of the book Complete Guide to the 1993 Waco Compound Standoff and Tragedy - Branch Davidians, David Koresh (Vernon Howell), Followers - ATF, FBI, Clinton Justice Dept., Janet Reno, Danforth and Treasury Reports by Progressive Management
Cover of the book Burma (Myanmar) in Perspective - Orientation Guide and Burmese Cultural Orientation: Geography, History, Economy, Society, Security, Military, Religion, Rangoon, Mandalay, Theravada Buddhism by Progressive Management
Cover of the book Asia-Pacific: A Strategic Assessment - China, Northeast Asia, and Southeast Asia - Territorial Disputes, Senkaku Islands, Economic Development, Secretary of State Hillary Clinton by Progressive Management
Cover of the book Overt Indicators of Islamic Extremism in Nigeria: Muslim Tradition, Possible Safe Haven for Terrorism, al-Qaeda Forces and Relationships, Dawa, Jihad, Madrassas, Sharia Law, Sunni and Salafi by Progressive Management
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy